Holen Sie sich die Stockscreener-App
7.26
2.68%
-0.20
Cormedix Inc Aktie (CRMD) Neueste Nachrichten
RBC Capital Maintains CorMedix(CRMD.US) With Buy Rating, Maintains Target Price $14 - Moomoo
CRMD vs. PRTA: Which Stock Should Value Investors Buy Now? - Zacks Investment Research
CorMedix (NASDAQ: CRMD) Strengthens Its Commercial Growth Story - kalkine.ca
US218939AB27 Bond Yield and Price — BONDSCOM:US218939AB27 - TradingView
(CRMD) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
CorMedix Inc (NASDAQ:CRMD) Stock Now Rated "Moderate Buy" by Wall Street Analysts - MarketBeat
150,656 Shares in CorMedix Inc $CRMD Acquired by Bank of America Corp DE - MarketBeat
CorMedix Inc. R (19KA.F) Q1 FY2026 earnings call transcript - Yahoo Finance
Diluted net income available to common stockholders of CorMedix Inc. – HAN:19KA - TradingView
Non-operating income (total) of CorMedix Inc. – HAN:19KA - TradingView
Price to cash flow ratio of CorMedix Inc. – HAN:19KA - TradingView
Cash flow from financing activities of CorMedix Inc. – HAN:19KA - TradingView
ETFs Investing in CorMedix Inc. Stocks - TradingView
CorMedix Inc. Balance Sheet – HAN:19KA - TradingView
Return on assets % of CorMedix Inc. – HAN:19KA - TradingView
Enterprise value of CorMedix Inc. – HAN:19KA - TradingView
CorMedix Inc. Revenue Breakdown – HAN:19KA - TradingView
Form 4 CorMedix Inc For: 27 September - Investing.com India
Form 4 CorMedix Inc For: 27 September By Investing.com - Investing.com Australia
Form 4 CorMedix Inc For: 27 September By Investing.com - Investing.com Nigeria
Form 4 CorMedix Inc For: 27 September By Investing.com - Investing.com UK
Is CRMD Stock a Buy Now After Strong Growth and New Risks? - Eastern Progress
The Technical Signals Behind (CRMD) That Institutions Follow - Stock Traders Daily
Cormedix Inc Lobbying Profile, 2015 - OpenSecrets
CorMedix (NASDAQ:CRMD) Shares Gap UpStill a Buy? - MarketBeat
CRMD Shareholder Alert: Rosen, a Longstanding and Trusted Firm, Encourages CorMedix Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class ActionCRMD - TMX Newsfile
Oppenheimer Initiates CorMedix at Outperform With $15 Price Target - Moomoo
Oppenheimer Initiates CorMedix at Outperform With $15 Price Target - marketscreener.com
CorMedix (NASDAQ:CRMD) Coverage Initiated by Analysts at Oppenheimer - MarketBeat
Oppenheimer initiates CorMedix stock coverage with outperform rating - Investing.com
CorMedix Inc. (CRMD) Edges Lower to $7.72 as Shares Test Support Above $7.33Option Breadth - careplusvn.com
CRMD News | CORMEDIX INC (NASDAQ:CRMD) - ChartMill
Cormedix Stock Price Forecast. Should You Buy CRMD? - StockInvest.us
CorMedix Inc (NASDAQ: CRMD) Share Price, CRMD Stock News, CRMD Share Price & Updates - kalkine.ca
CorMedix Inc. (CRMD) Stock Analysis: Biotech Innovator With A 97.69% Potential Upside - DirectorsTalk Interviews
CorMedix (CRMD) Down -1.15% — 3 Warning Signs Investors Should See 2026-09-17Small Cap Breakouts - careplusvn.com
Why Did CRMD Stock Tumble Over 11% Today? - Stocktwits
CorMedix at Wells Fargo 21st annual healthcare conference: growth, risk By Investing.com - Investing.com Canada
CorMedix at Wells Fargo 21st annual healthcare conference: growth, risk By Investing.com - Investing.com UK
CorMedix Inc (NASDAQ:CRMD) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
CorMedix (CRMD) Just Tripled Its Profits, But Guidance Barely Budged - finance.yahoo.com
GOOG: Alphabet IncOrdinary SharesClass C Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
Wall Street Analysts Think CorMedix (CRMD) Could Surge 67.73%: Read This Before Placing a Bet - finance.yahoo.com
Wall Street Analysts Think CorMedix (CRMD) Could Surge 67.73%: Read This Before Placing a Bet - Zacks Investment Research
Bank of New York Mellon Corp Takes Position in CorMedix Inc $CRMD - MarketBeat
The Technical Signals Behind (CRMD) That Institutions Follow - Stock Traders Daily
243,232 Shares in CorMedix Inc $CRMD Purchased by Empowered Funds LLC - MarketBeat
CorMedix (CRMD) COO holds 270K shares after cost-covering share withholding - Stock Titan
CorMedix Therapeutics to Participate in the Wells Fargo Healthcare Conference - finance.yahoo.com
CorMedix will meet investors in Boston for a Wells Fargo chat - Stock Titan
4.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):